Skip to main content
SpringerLink
Log in

Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes

  • Short Communications
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Allen RC, Losse LD (1976) Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun 69:245–252

    PubMed  Google Scholar 

  2. Broek H (1980) Treatment of Pruriga nodularis with thalidomide. Arch Dermatol 116:571–572

    Article  PubMed  Google Scholar 

  3. Faure M, Thivolet J, Gaucherand M (1980) Inhibition of PMN leukocytes chemotaxis by thalidomide. Arch Dermatol Res 269:275–280

    PubMed  Google Scholar 

  4. Goihman-Yahr M, Convit J, Rodriguez-Ochoa G, Aranzazu N, Villalba-Pimentel L, Ocanto A, Goméz ME (1978) Significance of neutrophil activation in reactional lepromatous leprosy: Effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. Int Arch Allergy Appl Immunol 57:317–332

    PubMed  Google Scholar 

  5. Hastings RC, Morales MJ (1978) The effect of thalidomide on neutrophil function. Int J Lepr 46:120

    Google Scholar 

  6. Klebanoff SJ, Rosen H (1978) Ethylene formation by polymorphonuclear leukocytes. J Exp Med 148:490–506

    Article  PubMed  Google Scholar 

  7. Knop J, Happle R, Bonsmann G, Vakilzadeh F, Macher E (1981) Treatment of chronic discoid lupus erythematosus with thalidomide. Arch Dermatol Res 271:165–170

    Google Scholar 

  8. Mascaro JM, Lecha M, Torras H (1979) Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphatae and aphtosis. Arch Dermatol 115:636–637

    Article  Google Scholar 

  9. Massey V (1959) The microestimation ofsuccinate and the extinction coefficient of cytochrome C. Biochem Biophys Acta 34:255–256

    Article  PubMed  Google Scholar 

  10. McCord JM (1974) Free radicals and inflammation: Protection of synovial fluids by superoxide dismutase. Science 185:529–531

    PubMed  Google Scholar 

  11. Miyachi Y, Takigawa M, Imamura S (1981) Suppression of DNCB-induced irritant dermatitis by colchicine. Acta Derm Venereol (Stockh) 61307–311

    Google Scholar 

  12. Miyachi Y, Danno K, Imamura S (1981) Suppression of active Arthus reaction by colchicine. Br J Dermatol 105:279–283

    PubMed  Google Scholar 

  13. Miyachi Y, Ozaki M (1981) Thalidomide does not affect polymorphonuclear leukocyte (PMN) chemotaxis. Jpn J Lepr 50:62–64

    Google Scholar 

  14. Miyachi Y, Niwa Y (1982) Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 107:209–214

    PubMed  Google Scholar 

  15. Miyachi Y, Yanase K, Imamura S, Niwa Y (1982) Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis. Arch Dermatol Res 274

  16. Moran CJ, Ryder G, Turk JL, Waters MFR (1972) Evidence for circulating immune complexes in lepromatous leprosy. Lancet II:572–573

    Article  Google Scholar 

  17. Root RK, Metcalf JA (1977) H2O2 release from human granulocytes during phagocytosis. J Clin Invest 60:1266–1279

    PubMed  Google Scholar 

  18. Salin ML, McCord JM (1975) Free radicals and inflammation: Protection of phagocytosing leukocytes by superoxide dismutase. J Clin Invest 56:1319–1323

    PubMed  Google Scholar 

  19. Saul A, Flores O, Novales J (1976) Polymorphous light eruption: Treatment with thalidomide. Aust J Dermatol 17:17–21

    Google Scholar 

  20. Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303–308

    Google Scholar 

  21. Sheskin J (1976) Thalidomide in lepra reaction. Int J Dermatol 14:575–576

    Google Scholar 

  22. Turk JL (1976) Leprosy as a model of subacute and chronic immunologic diseases. J Invest Dermatol 67:457–463

    Article  PubMed  Google Scholar 

  23. Ulrich M, Salas B, Convit J (1971) Thalidomide activity in experimental arthus and anaphylactic reactions. Int J Lepr 39:131–135

    Google Scholar 

  24. Waters MFR, Laing ABC, Ambikapathy A, Lennard-Jones JE (1979) Treatment of ulcerative colitis with thalidomide. Br Med J 24:792

    Google Scholar 

  25. Wemambu SNC, Turk JL, Waters MFR, Rees RJW (1969) Erythema nodosum leprosum: A clinical manifestation of the Arthus phenomenon. Lancet II:933–935

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Dermatology, Faculty of Medicine, Kyoto University, Kyoto, Japan

    Y. Miyachi & M. Ozaki

  2. Niwa Institute for Immunology, Kochi, Japan

    K. Uchida & Y. Niwa

Authors
  1. Y. Miyachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Niwa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyachi, Y., Ozaki, M., Uchida, K. et al. Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes. Arch Dermatol Res 274, 363–367 (1982). https://doi.org/10.1007/BF00403742

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00403742

Key words

Search

Navigation